XML 123 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Net Loss Per Share Attributable to Common Stockholders (Tables)
12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted The shares issued in the IPO, the shares issued pursuant to the exercise by the underwriters of an option to purchase additional shares, and the shares of Class A and Class B common stock issued upon conversion of the outstanding shares of convertible preferred stock in the IPO are included in the table below weighted for the period outstanding:
 
 
Year ended December 31,
 
 
2019
 
2018
2017
 
 
Class A(1)
 
Class B(2)
 
Class A
 
Class B(2)
Class A
 
Class B(2)
 
 
(in thousands, except per share amounts)
Net loss attributable to common stockholders
 
$
(12,084
)
 
$
(39,466
)
 
N/A
 
$
(30,935
)
N/A
 
$
(32,450
)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted
 
16,022

 
52,328

 
N/A
 
24,376

N/A
 
23,402

Net loss per share attributable to common stockholders, basic and diluted
 
$
(0.75
)
 
$
(0.75
)
 
N/A
 
$
(1.27
)
N/A
 
$
(1.39
)
__________
(1)
Class A common stock includes the issuance of 12.9 million shares of Class A common stock issued by us in connection with our IPO and shares issued upon the exercise of options subsequent to our IPO.
(2)
Class B common stock includes, for all periods presented, the conversion of all of our preferred stock into an aggregate of 53.6 million shares of our Class B common stock upon closing of the IPO.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have been antidilutive are as follows:
 
 
Number of Shares
 
 
As of December 31,
 
 
2019
 
2018
 
 
(in thousands)
Convertible preferred stock
 

 
53,630

Stock options
 
11,269

 
7,847

RSUs
 
1,641

 

Early exercised stock options
 
200

 
245

Convertible common stock warrants
 
183

 

Convertible preferred stock warrants
 

 
518

Shares issuable pursuant to the ESPP
 
247

 

Total
 
13,540

 
62,240